Back to search results

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

Abroad (travel likely)RecruitingPHASE3

Conditions

ART · Pre-Eclampsia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU Angers, Angers, France

    Contact: Study coordinator (Pierre-Emmanuel BOUET, MD)
    Contact: Principal Investigator (Pierre-Emmanuel BOUET)

  • CHU Bordeaux, Bordeaux, France

    Contact: Study coordinator (Loic Sentilhes, MD)
    Contact: Principal Investigator (Loic SENTILHES)

  • CHU Clermont-Ferrand, Clermont-Ferrand, France

    Contact: Study coordinator (Amélie DELABAERE, MD)
    Contact: Principal Investigator (Amélie DELABAERE)

  • CHU Dijon-Bourgogne, Dijon, France

    Contact: Study coordinator (Emmanuel Simon, MD)
    Contact: Principal Investigator (Emmanuel SIMON)

  • CHU Lille, Lille, France

    Contact: Study coordinator (Véronique Debarge, MD)
    Contact: Principal Investigator (Véronique DEBARGE)

  • HCL - Groupement Hospitalier Est, Hôpital Femme Mère Enfant, Lyon, France

    Contact: Study coordinator (Mona Massoud, MD)
    Contact: Principal Investigator (Mona MASSOUD)

  • AP-HM Hôpital de la Conception, Marseille, France

    Contact: Study coordinator (Blandine Courbière, MD)
    Contact: Principal Investigator (Blandine COURBIERE)

  • AP-HM Hôpital Nord, Marseille, France

    Contact: Study coordinator (Julie Blanc, MD)
    Contact: Principal Investigator (Julie BLANC)

  • CHU Montpellier, Montpellier, France

    Contact: Study coordinator (Noémie Ranisavljevic, MD)
    Contact: Principal Investigator (Noémie RANISAVLJEVIC)

  • CHRU Nancy, Nancy, France

    Contact: Study coordinator (Catherine Zuili Lamy, MD)
    Contact: Principal Investigator (Catherine ZUILI LAMY)

  • CHU Nantes, Nantes, France

    Contact: Study coordinator (Vincent Dochez, MD)
    Contact: Principal Investigator (Vincent DOCHEZ)

  • CHU Nîmes, Nîmes, France

    Contact: Study coordinator (Stéphanie Huberlant, MD)
    Contact: Principal Investigator (Stéphanie HUBERLANT)

  • Groupe hospitalier St Joseph, Paris, France

    Contact: Study coordinator (Elie Azria, MD)
    Contact: Principal Investigator (Elie AZRIA)

  • Hôpital Armand - Trousseau, Paris, France

    Contact: Study coordinator (Gilles Kayem, MD)
    Contact: Principal Investigator (Gilles KAYEM)

  • Hôpital Cochin, Paris, France

    Contact: Study coordinator (Vassilis Tsatsaris, MD)
    Contact: Principal Investigator (Vassilis TSATSARIS)

  • CHI Poissy Saint Germain en Laye, Poissy, France

    Contact: Study coordinator (Paul Berveiller, MD)
    Contact: Principal Investigator (Paul BERVEILLER)

  • CHU Poitiers, Poitiers, France

    Contact: Study coordinator (Aurélie Brossard Violeau, MD)
    Contact: Principal Investigator (Aurélie BROSSARD VIOLEAU)

  • CHU Rennes, Rennes, France

    Contact: Study coordinator (Céline Pimentel, MD)
    Contact: Principal Investigator (Céline PIMENTEL)

  • CHU Saint Etienne, Hôpital Nord, Saint-Etienne, France

    Contact: Study coordinator (Tiphaine Barjat, MD)
    Contact: Principal Investigator (Tiphaine BARJAT)

  • CHU Strasbourg, Strasbourg, France

    Contact: Study coordinator (Catherine Rongières, MD)
    Contact: Principal Investigator (Catherine RONGIERE)

  • CHU Toulouse, Toulouse, France

    Contact: Study coordinator (Paul GUERBY, MD) · guerby.p@chu-toulouse.fr
    Contact: Principal Investigator (Christophe VAYSSIERE, MD)
Study leads

  • Christophe VAYSSIERE, MD

    Principal Investigator

    University Hospital, Toulouse

View source on ClinicalTrials.gov(opens in a new tab)